Viewing Study NCT00431561

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 1:06 PM

Ignite Modification Date: 2026-01-01 @ 9:12 AM

Study NCT ID: NCT00431561

Status: COMPLETED

Last Update Posted: 2013-12-03

First Post: 2007-02-05

Is Gene Therapy: True

Has Adverse Events: False

Brief Title: Phase IIb Clinical Trial With TGF-β2 Antisense Compound AP 12009 for Recurrent or Refractory High-grade Glioma

Sponsor: Isarna Therapeutics GmbH

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module